The FTC fails to acknowledge the benefits of pharmacy benefit managers and wrong blames them for high drug prices.
CCAGW Urges House of Representatives to Oppose H.R. 8371
Title V of H.R. 8371 would slow deployments and improvements to the VA electronic health record management system.
FDA Has Once Again Delayed Its Menthol Ban
A federal flavor ban is clearly unpopular and would create black markets.
Southern States Advance Harmful Tobacco Legislation
Pre-market application requirements for THR products injure public health and finances.
Vermont Governor Takes the Right Approach to Tobacco Harm Reduction
Gov. Scott should be praised for his commonsense approach to legislating tobacco harm reduction products.
Lives Hang in the Balance While the FDA Bureaucracy Churns
The government red tape contributing to the backlog of PMTAs has put consumers at risk with illicit products.
Medicare Advantage Should Not Be Disadvantaged
Taxpayers and beneficiaries should be concerned with the Biden administration’s proposed cuts to Medicare Advantage.
Reflecting on Privacy Laws During Data Privacy Week
Data Privacy Week is an opportunity to review can be done to protect data and learn what privacy laws are being proposed.
FDA Hurts Patients By Authorizing Florida’s Drug Importation Program
On January 5, 2024, the U.S. FDA authorized Florida’s drug importation program.
Misguided Use of March-In Rights Will Harm Patients
The use of march-in rights to steal intellectual property will neither lower costs nor create more access to healthcare.